Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • AAL vs MRNA✓SelectedUSD · MRNAAAL vs MRNA performance historyLatest closeAs of-2.23%11/19
Stock and ETF performance explorer

AAL vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+5.5%
MRNA return
+318.7%
Excess return
-313.2%
Maximum drawdown
-35.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 6mo.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-2.2%+1.3%-3.5%-2.2%
7D-4.4%-13.8%+9.4%-4.3%
30D+5.0%-17.7%+22.7%+5.2%
3M-8.2%+14.3%-22.5%-8.2%
6M+5.5%+336.0%-330.5%+2.8%
All+5.5%+318.7%-313.2%+2.8%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 6mo: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

6mo analysis · Full analysis span regression · 6 months rolling